Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Jennifer Diamond

Concepts (280)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
15
2023
157
6.770
 Why?
Breast Neoplasms
23
2023
1842
4.750
 Why?
Antineoplastic Agents
23
2023
1872
2.740
 Why?
Immunoconjugates
7
2023
87
2.670
 Why?
Antineoplastic Combined Chemotherapy Protocols
19
2023
1356
2.670
 Why?
Pyrimidines
9
2021
372
2.520
 Why?
Receptor, ErbB-2
11
2023
299
2.000
 Why?
Protein Kinase Inhibitors
10
2022
779
1.810
 Why?
Neoplasms
14
2022
2082
1.760
 Why?
Piperazines
4
2020
309
1.730
 Why?
Paclitaxel
6
2022
187
1.650
 Why?
Camptothecin
9
2023
95
1.630
 Why?
Pyrazoles
6
2021
361
1.450
 Why?
Quinoxalines
2
2020
60
1.330
 Why?
Ovarian Neoplasms
4
2020
386
1.320
 Why?
Azepines
3
2020
69
1.270
 Why?
Antibodies, Monoclonal, Humanized
9
2021
654
1.230
 Why?
Cyclin-Dependent Kinase 4
2
2018
33
1.130
 Why?
Cyclin-Dependent Kinase 6
2
2018
37
1.110
 Why?
Histone Deacetylase Inhibitors
3
2023
197
1.030
 Why?
Neutropenia
4
2022
122
0.910
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1140
0.840
 Why?
Xenograft Model Antitumor Assays
11
2021
693
0.800
 Why?
beta Catenin
2
2020
208
0.770
 Why?
Female
48
2023
59115
0.770
 Why?
Breast Neoplasms, Male
2
2018
28
0.750
 Why?
Lymphocytes, Tumor-Infiltrating
2
2020
111
0.710
 Why?
Chemotherapy, Adjuvant
4
2023
332
0.710
 Why?
Receptors, Estrogen
3
2021
371
0.700
 Why?
Cancer Care Facilities
1
2020
29
0.700
 Why?
Maximum Tolerated Dose
9
2022
182
0.700
 Why?
Benzoxazoles
1
2020
16
0.690
 Why?
Carcinoma, Lobular
2
2018
44
0.690
 Why?
eIF-2 Kinase
1
2019
24
0.660
 Why?
Tumor Microenvironment
3
2020
428
0.650
 Why?
Humans
60
2023
113531
0.650
 Why?
Aged
22
2023
18944
0.620
 Why?
Anthracyclines
3
2023
42
0.620
 Why?
Drug Resistance, Neoplasm
4
2020
636
0.610
 Why?
Taxoids
3
2023
93
0.610
 Why?
Wnt Signaling Pathway
1
2019
145
0.590
 Why?
Carcinoma, Ductal, Breast
1
2018
76
0.570
 Why?
Aurora Kinase A
4
2020
51
0.570
 Why?
Trastuzumab
4
2023
89
0.570
 Why?
Pyrazines
2
2018
70
0.550
 Why?
Myocardial Infarction
1
2023
932
0.540
 Why?
Colonic Neoplasms
1
2018
210
0.530
 Why?
Pyridines
2
2018
417
0.520
 Why?
Neoadjuvant Therapy
1
2018
305
0.520
 Why?
Nuclear Proteins
2
2023
584
0.510
 Why?
Angiopoietin-1
1
2015
10
0.490
 Why?
Angiopoietin-2
1
2015
11
0.490
 Why?
Tumor Suppressor Protein p53
3
2016
443
0.480
 Why?
Cell Line, Tumor
9
2022
2690
0.470
 Why?
Colorectal Neoplasms
5
2022
592
0.470
 Why?
Middle Aged
23
2021
26552
0.470
 Why?
Medicare
4
2023
661
0.470
 Why?
Uterine Cervical Neoplasms
1
2017
208
0.460
 Why?
Adult
23
2022
30245
0.420
 Why?
Cell Proliferation
8
2020
2164
0.420
 Why?
Dose-Response Relationship, Drug
6
2022
1822
0.420
 Why?
Treatment Outcome
12
2022
9006
0.420
 Why?
Tumor Suppressor Proteins
1
2015
283
0.410
 Why?
Proto-Oncogene Proteins c-met
1
2013
67
0.410
 Why?
Antineoplastic Agents, Immunological
3
2019
152
0.410
 Why?
Recombinant Fusion Proteins
1
2015
599
0.400
 Why?
Point Mutation
1
2013
214
0.400
 Why?
Triazoles
1
2013
123
0.390
 Why?
Mitochondria
1
2017
735
0.380
 Why?
Angiogenesis Inhibitors
3
2018
212
0.370
 Why?
Mice, Nude
6
2020
625
0.370
 Why?
Neoplasm Recurrence, Local
4
2021
848
0.360
 Why?
Carcinoma, Renal Cell
1
2013
168
0.360
 Why?
Heart Failure
1
2023
1955
0.360
 Why?
Histones
3
2023
528
0.360
 Why?
Clinical Trials, Phase I as Topic
2
2020
45
0.350
 Why?
Neoplasm Metastasis
4
2020
519
0.350
 Why?
Biomarkers, Tumor
2
2014
1029
0.350
 Why?
Aged, 80 and over
8
2020
6296
0.340
 Why?
Genes, BRCA2
1
2009
24
0.340
 Why?
Genes, BRCA1
1
2009
31
0.330
 Why?
Molecular Targeted Therapy
3
2019
345
0.330
 Why?
Neoplasm Staging
5
2021
1159
0.320
 Why?
BRCA2 Protein
1
2009
41
0.320
 Why?
Kidney Neoplasms
1
2013
324
0.320
 Why?
Thrombophilia
1
2009
61
0.320
 Why?
Pregnancy Complications, Neoplastic
1
2009
51
0.320
 Why?
Quinolines
2
2021
127
0.310
 Why?
Aromatase Inhibitors
2
2018
49
0.300
 Why?
DNA-Binding Proteins
1
2015
1286
0.300
 Why?
Receptors, Progesterone
2
2021
319
0.290
 Why?
Mice
9
2021
14679
0.290
 Why?
Antibodies, Monoclonal
3
2020
1236
0.290
 Why?
Apoptosis
6
2022
2288
0.280
 Why?
Models, Biological
1
2014
1589
0.270
 Why?
Liver Neoplasms
1
2009
504
0.240
 Why?
Lung Neoplasms
1
2017
2148
0.230
 Why?
Disease Models, Animal
3
2021
3470
0.230
 Why?
United States
5
2023
12137
0.230
 Why?
Cyclophosphamide
2
2018
214
0.220
 Why?
Radiosurgery
2
2019
298
0.220
 Why?
Animals
11
2021
31162
0.220
 Why?
Doxorubicin
2
2018
283
0.210
 Why?
Disease Progression
4
2019
2364
0.200
 Why?
Biopsy
2
2018
1024
0.200
 Why?
Cyclin-Dependent Kinase 9
1
2022
9
0.200
 Why?
Histone Deacetylase 1
1
2022
16
0.200
 Why?
Administration, Oral
3
2022
719
0.200
 Why?
Aurora Kinases
2
2012
28
0.190
 Why?
Fluorouracil
1
2022
151
0.190
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
41
0.190
 Why?
Topoisomerase I Inhibitors
2
2022
15
0.190
 Why?
Arrhythmias, Cardiac
1
2023
281
0.190
 Why?
Acetylation
1
2022
208
0.190
 Why?
Male
13
2021
55112
0.190
 Why?
Biliary Tract Neoplasms
1
2021
20
0.180
 Why?
Immunotherapy
2
2023
472
0.180
 Why?
Androstadienes
1
2021
97
0.180
 Why?
Fatigue
2
2022
292
0.180
 Why?
Diarrhea
2
2019
170
0.180
 Why?
Necrosis
2
2019
210
0.180
 Why?
Carboplatin
1
2021
134
0.180
 Why?
Heterografts
1
2021
117
0.180
 Why?
Drug Administration Schedule
3
2017
712
0.180
 Why?
Hospitals, University
1
2021
169
0.180
 Why?
Clinical Trials as Topic
3
2016
922
0.180
 Why?
Histone Deacetylases
1
2022
194
0.170
 Why?
Benzodiazepines
1
2021
114
0.170
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
55
0.170
 Why?
Immune System
1
2021
167
0.170
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
97
0.170
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
22
0.170
 Why?
Kaplan-Meier Estimate
1
2021
809
0.160
 Why?
Tumor Cells, Cultured
1
2020
834
0.160
 Why?
Aquaporin 4
1
2019
86
0.150
 Why?
Albumins
1
2019
88
0.150
 Why?
Maintenance Chemotherapy
1
2018
21
0.150
 Why?
Antibodies, Bispecific
1
2018
32
0.150
 Why?
Vascular Endothelial Growth Factor A
2
2018
496
0.150
 Why?
Nausea
1
2018
96
0.150
 Why?
Aminopyridines
1
2018
81
0.150
 Why?
Mice, Inbred BALB C
1
2020
1136
0.150
 Why?
Mastectomy
1
2018
99
0.150
 Why?
Drug Therapy, Combination
1
2020
944
0.150
 Why?
Breast
1
2018
138
0.150
 Why?
Radiotherapy, Adjuvant
1
2018
182
0.140
 Why?
Benzimidazoles
1
2018
137
0.140
 Why?
Purines
1
2018
158
0.140
 Why?
Imidazoles
1
2018
203
0.140
 Why?
Nanoparticles
1
2021
308
0.140
 Why?
Topotecan
1
2017
10
0.140
 Why?
Isoflavones
1
2017
16
0.140
 Why?
Calcium-Binding Proteins
1
2018
201
0.140
 Why?
Survival Analysis
1
2020
1203
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2019
193
0.140
 Why?
Hypertension
2
2018
1051
0.140
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
15
0.140
 Why?
Carbolines
1
2017
27
0.140
 Why?
Inhibitory Concentration 50
2
2016
74
0.140
 Why?
Neoplasms, Radiation-Induced
1
2016
66
0.130
 Why?
Cell Survival
1
2019
1004
0.130
 Why?
Insulin-Like Growth Factor I
1
2018
280
0.130
 Why?
GPI-Linked Proteins
1
2016
53
0.130
 Why?
Retrospective Studies
3
2021
12504
0.130
 Why?
Adaptor Proteins, Signal Transducing
1
2018
367
0.130
 Why?
Neoplasms, Second Primary
1
2016
92
0.120
 Why?
Phosphorylation
1
2019
1537
0.120
 Why?
Tumor Protein p73
1
2015
14
0.120
 Why?
Antibodies, Neoplasm
1
2015
30
0.120
 Why?
Hodgkin Disease
1
2016
121
0.120
 Why?
Risk Reduction Behavior
1
2016
200
0.120
 Why?
Maytansine
1
2014
13
0.120
 Why?
Demography
1
2015
255
0.110
 Why?
Randomized Controlled Trials as Topic
1
2019
1205
0.110
 Why?
Survival Rate
2
2019
1634
0.110
 Why?
Brain Edema
1
2014
52
0.110
 Why?
Drug Interactions
1
2015
332
0.110
 Why?
Protein Kinases
1
2015
300
0.110
 Why?
Analgesics, Opioid
1
2021
770
0.110
 Why?
Sulfones
1
2014
97
0.110
 Why?
Time Factors
2
2020
6032
0.110
 Why?
Threonine
1
2013
40
0.110
 Why?
Glycine
1
2014
151
0.110
 Why?
Drug Evaluation, Preclinical
1
2013
158
0.100
 Why?
Tumor Stem Cell Assay
1
2012
33
0.100
 Why?
Drug Design
1
2013
146
0.100
 Why?
Methionine
1
2013
144
0.100
 Why?
Heterozygote
1
2013
248
0.100
 Why?
Disease-Free Survival
1
2014
617
0.100
 Why?
Treatment Failure
1
2013
323
0.100
 Why?
In Situ Hybridization, Fluorescence
1
2013
306
0.100
 Why?
Computational Biology
1
2015
527
0.100
 Why?
Neovascularization, Pathologic
1
2013
280
0.100
 Why?
Risk Assessment
1
2020
2953
0.090
 Why?
Cellular Senescence
1
2012
150
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
305
0.090
 Why?
Cluster Analysis
1
2012
448
0.090
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
223
0.090
 Why?
Colorado
1
2020
4061
0.090
 Why?
Carcinoma in Situ
1
2011
43
0.090
 Why?
Mutation
2
2012
3313
0.090
 Why?
Brain Neoplasms
2
2019
964
0.090
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
85
0.090
 Why?
Sequence Analysis, DNA
1
2013
716
0.090
 Why?
Tumor Burden
1
2010
257
0.080
 Why?
Pregnancy Trimester, Second
1
2009
65
0.080
 Why?
Keratinocytes
1
2010
215
0.080
 Why?
Mastectomy, Segmental
1
2009
76
0.080
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
68
0.080
 Why?
Pregnancy Trimester, First
1
2009
125
0.080
 Why?
Apoptosis Regulatory Proteins
1
2009
168
0.080
 Why?
Lymph Node Excision
1
2009
140
0.080
 Why?
Risk Factors
1
2020
8606
0.070
 Why?
Prognosis
2
2018
3318
0.070
 Why?
Risk
1
2009
807
0.070
 Why?
Cell Adhesion Molecules
2
2019
160
0.070
 Why?
Infusions, Intravenous
2
2019
368
0.070
 Why?
Antigens, Neoplasm
2
2019
222
0.070
 Why?
CD8-Positive T-Lymphocytes
2
2023
686
0.070
 Why?
Gene Expression Profiling
1
2012
1510
0.070
 Why?
Cell Cycle Proteins
2
2023
543
0.060
 Why?
Cell Cycle
2
2018
538
0.060
 Why?
Combined Modality Therapy
2
2019
1114
0.060
 Why?
Signal Transduction
2
2014
4439
0.050
 Why?
Mesylates
1
2022
7
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
62
0.050
 Why?
Clinical Protocols
1
2023
231
0.050
 Why?
Liver
1
2009
1630
0.050
 Why?
Chimerism
1
2021
28
0.050
 Why?
Lymphoid Tissue
1
2021
62
0.050
 Why?
Lymphocyte Subsets
1
2021
79
0.040
 Why?
Mice, SCID
1
2021
311
0.040
 Why?
SEER Program
1
2021
193
0.040
 Why?
Hormones
1
2020
132
0.040
 Why?
Mice, Inbred NOD
1
2021
551
0.040
 Why?
Infant, Newborn
1
2009
5032
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.040
 Why?
Tissue Distribution
1
2018
280
0.040
 Why?
Pregnancy
1
2009
5490
0.040
 Why?
Anemia
1
2019
141
0.040
 Why?
Cetuximab
1
2016
89
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
107
0.030
 Why?
Neoplasm Transplantation
1
2016
227
0.030
 Why?
Retreatment
1
2016
67
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
512
0.030
 Why?
Platinum
1
2016
38
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
181
0.030
 Why?
Transcription Factors
1
2023
1497
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
227
0.030
 Why?
Biomarkers
2
2016
3389
0.030
 Why?
History, Ancient
1
2015
47
0.030
 Why?
Mice, Knockout
1
2021
2523
0.030
 Why?
Databases, Genetic
1
2015
205
0.030
 Why?
DNA Damage
1
2017
345
0.030
 Why?
Opioid-Related Disorders
1
2021
412
0.030
 Why?
Phenotype
1
2021
2754
0.030
 Why?
Drug Combinations
1
2013
285
0.030
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
382
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
239
0.020
 Why?
Immunohistochemistry
1
2016
1604
0.020
 Why?
Cohort Studies
1
2021
4880
0.020
 Why?
Transcription, Genetic
1
2017
1282
0.020
 Why?
Biopsy, Needle
1
2011
180
0.020
 Why?
Enzyme Inhibitors
1
2014
737
0.020
 Why?
Proto-Oncogene Proteins
1
2014
595
0.020
 Why?
HT29 Cells
1
2010
35
0.020
 Why?
ErbB Receptors
1
2013
553
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
390
0.020
 Why?
Follow-Up Studies
1
2018
4384
0.020
 Why?
Patient Selection
1
2013
625
0.020
 Why?
Ki-67 Antigen
1
2010
101
0.020
 Why?
Patient Satisfaction
1
2013
570
0.020
 Why?
Capillary Permeability
1
2010
134
0.020
 Why?
Membrane Proteins
1
2015
1008
0.020
 Why?
Positron-Emission Tomography
1
2010
260
0.020
 Why?
Algorithms
1
2015
1462
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3013
0.020
 Why?
Tomography, X-Ray Computed
1
2016
2269
0.020
 Why?
Brain
1
2014
2309
0.010
 Why?
Young Adult
1
2014
10400
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (280) concept(s)
_
Co-Authors Expand Description
See all (58) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)